Subtyping muscle-invasive bladder cancer to assess clinical response to trimodality therapy.

被引：0
|
作者：
Efstathiou, Jason A.
Gibb, Ewan
Miyamoto, David Tomoaki
Wu, Chin-Lee
Drumm, Michael
Lehrer, Jonathan
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.287
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
287
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Subtyping Muscle-Invasive Bladder Cancer to Assess Clinical Response to Trimodality Therapy
    Efstathiou, J. A.
    Gibb, E.
    Miyamoto, D. T.
    Wu, C. L.
    Drumm, M. R.
    Lehrer, J.
    Ashab, H. A. D. M.
    Erho, N. G.
    du Plessis, M.
    Ong, K.
    Bhat, A.
    Mouw, K.
    Davicioni, E.
    Shipley, W. U.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S118 - S118
  • [2] Genomic Determinants of Response to Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Kamran, S. C.
    Zhou, Y.
    Otani, K.
    Drumm, M. R.
    Otani, Y.
    Wu, S.
    Wu, C. L.
    Borger, D.
    Lennerz, J. K.
    Van Allen, E. M.
    Willers, H.
    Hong, T. S.
    Liu, Y.
    Davicioni, E.
    Gibb, E.
    Shipley, W. U.
    Mouw, K. W.
    Efstathiou, J. A.
    Miyamoto, D. T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S24 - S24
  • [3] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Johnson, Skyler B.
    Yu, James B.
    [J]. CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [4] Trimodality Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer
    Chen, Ronald C.
    Shipley, William U.
    Efstathiou, Jason A.
    Zietman, Anthony L.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (08): : 952 - 960
  • [5] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Skyler B. Johnson
    James B. Yu
    [J]. Current Oncology Reports, 2018, 20
  • [6] Mutational Landscape and Genetic Determinants of Response to Trimodality Therapy in Muscle-Invasive Bladder Cancer
    Miyamoto, D. T.
    Kamran, S. C.
    Mouw, K. W.
    Wu, C. L.
    Wu, S.
    Ukleja, J.
    Kusaka, E.
    Otani, K.
    Borger, D.
    Lennerz, J. K.
    Van Allen, E. M.
    Willers, H.
    Hong, T. S.
    Shipley, W. U.
    Efstathiou, J. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E861 - E861
  • [7] Impact of selection bias on outcomes in veterans with muscle-invasive bladder cancer receiving bladder preserving trimodality therapy.
    Kumar, Abhishek
    Kotha, Nikhil V.
    Nelson, Tyler J.
    Cherry, Daniel R.
    Stewart, Tyler F.
    Mckay, Rana R.
    Rose, Brent S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [8] Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer
    Nguyen, Eric K.
    Yu, Hang
    Pond, Gregory
    Shayegan, Bobby
    Pinthus, Jehonathan H.
    Kapoor, Anil
    Mukherjee, Som D.
    Neville, Alan
    Lalani, Aly-Khan A.
    Hotte, Sebastien J.
    Corbett, Thomas B.
    Dayes, Ian S.
    Lukka, Himanshu R.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2020, 14 (04): : 122 - 129
  • [9] Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Royce, Trevor J.
    Liu, Yuan
    Milowsky, Matthew, I
    Efstathiou, Jason A.
    Jani, Ashesh B.
    Fischer-Valuck, Benjamin
    Patel, Sagar A.
    [J]. CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : 362 - 368
  • [10] Trimodality Therapy for Muscle-Invasive Bladder Cancer: Concurrent Chemotherapy is Not Enough
    Winquist, Eric
    Booth, Christopher M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (24) : 2709 - +
12345